About Conference

Conference Backgroud

Asia Pharma R&D Innovation 2019 is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CROs, academic institutions, technology and solution provider, investors , Lawyer and all the way down to other industrial stakeholders to assess the latest industrial trends, R&D strategies, partnership models and technology advancements in China and Asia.

This is the largest annual pharmaceutical R&D gathering in China featuring multiple conferences, summits and seminars that cover the entire value chain of the pharma R&D. Asia Pharma R&D Innovation 2019 will show you how you can access the important markets in Asia that matters most to your R&D strategies. Our aim is to promote global and regional deal making between pharmas, biotechs and academics in China and across other Asian countries and to leverage technologies to your advantage in promising drug discovery, screening, safety, clinical trials and R&D activities in the region.

Snapshot of APRDIC 2019:

• Asia’s R&D landscape from big pharma’s eyes
• How Collaboration is Driving Innovation in Research & Development ?
• Boosting China's new Drug Research and Development to Enhance Global Competitiveness
• Regulatory Data Protection, Patent Linkage and Patent Term Extension in New Drug Discovery and Development
• Tapping into Funding and Investment Opportunities on New Drug Discovery and Development in China
• Chinese BioPharma R&D Collaboration Opportunities and Development Models Innovation in the Future
• Case study of drug R&D and Oncology Therapeutic Focus
• Excellence in services – Technology showcase
• Omics,New Biomarker Discovery and Precision Medicine Development,Novel Technologies for Drug Discovery
• Clinical Trials Innovation
• Biomarker & Real World Data Based Decision Making in Drug Development
• Flexible and Efficient Data Management and Statistical Analysis
• Model-Driven Combined Design in Phase I/II Clinical Trials

Who should attend?

More than 300 participants are expected to attend “The 3rd Asia Pharma R&D Innovation Conference 2019, attracting the strong contingent throughout the Asia Pacific, USA and Europe. To breakdown, the participants will mainly come from:

By Attendees:
Chief Executive Officer
Chief Medical Officer
Chief Scientific Officer
SVP, VP, Head, Director of

Research and Development
R&D Business Development
Medical Affairs
Outsourcing and Externalization
Oncology/CNS/Diabetes Research
Biomarker and Translational Research
Licensing and Partnership
Clinical Trials

By Industry:
Animal Studies Services
Clinical Data Management
Clinical Research / Clinical Trials Services
Cold Chain Solutions
Compliance and Validation Services
Contract Research Services
Database / Data Mining
Drug Discovery Support Software
Electronic Data Capturing Systems
Genomic Research Tools and Equipments
High Performance Computing
Imaging Systems/Image Analysis
Legal Companies
Mass Spectrometry Analysis
Microarray Instruments
Private Equity
Proteomics Research Tools and Reagents
Protein/DNA Analyzing Software
Research Equipment and Consumables
Recruitment Agencies
Stem Cell Research Technologies
Technology Transfer/Licensing Services
Venture Capital Firms


World Business Forum Group is a creative business media corporate in China that leads its market in producing thought leadership, cutting edge, and technology driven summits, conferences and trade shows to clients from the Fortune 500 for their needs of high profile business networking and commercial deal making in Asia.

We also provide unrivalled expertise in analysis, market development and event management services to the global pharmaceutical, healthcare, biopharmaceutical, food and financial sectors to assist them in developing world-leading brands in China and other Asian emerging markets. We can help them achieve their commercial objectives in key areas such as market research, promotion, finding business partners and talent development as well as meeting the demands of local legislation.